TriSalus Life Sciences Completes Merger With MedTech Acquisition Corporation

San Diego – August 16, 2023 – Cooley advised TriSalus Life Sciences, an oncology company with a focus on treatments for patients with liver and pancreatic tumors, on its merger with MedTech Acquisition Corporation. Partners Matthew Browne, Rama Padmanabhan and Rupa Briggs – along with associates Rajdeep Bains, Alexander Gefter, Brett Dovman, Jayden Martinez and Pitrina Gilger – led the Cooley team advising TriSalus.

The merger will advance TriSalus’ technology development and sales growth, as well as move SD-101 – an investigational immunotherapeutic designed to improve patient outcomes by treating the immunosuppressive environment created by tumors – into phase 2 clinical trial and provide cash runway through mid-2024 to fund key milestones.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has nearly 1,400 lawyers across 18 offices in the United States, Asia and Europe, and a total workforce of more than 3,000.